Related Experiment Video
Updated: Apr 7, 2026
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Bone metastases in lung cancer. Potential novel approaches to therapy
Silvestre Vicent1,2,3, Naiara Perurena1, Ramaswamy Govindan4
11 Division of Oncology, Center for Applied Medical Research, and.
Abstract:
The skeleton is a common site of metastases in lung cancer, an event associated with significant morbidities and poor outcomes. Current antiresorptive therapies provide limited benefit, and novel strategies of prevention and treatment are urgently needed. This review summarizes the latest advances and new perspectives on emerging experimental and clinical approaches to block this deleterious process. Progress propelled by preclinical models has led to a deeper understanding on the complex interplay of tumor cells in the osseous milieu, unveiling potential new targets for drug development. Improvements in early diagnosis through the use of sophisticated imaging techniques with bone serum biomarkers are also discussed in the context of identifying patients at risk and monitoring disease progression during the course of treatment.
Insights
Lung cancer commonly spreads to the skeleton, causing poor outcomes. New research explores novel treatments and diagnostic tools to combat bone metastases and improve patient survival.
Area of Science:
- Oncology
- Skeletal Biology
- Cancer Metastasis
Background:
- Bone metastases are a frequent complication of lung cancer, leading to severe morbidity and reduced survival.
- Existing antiresorptive therapies offer limited efficacy for managing skeletal-related events in lung cancer patients.
Purpose of the Study:
- To review recent advancements and emerging strategies for preventing and treating lung cancer bone metastases.
- To highlight new therapeutic targets and diagnostic approaches for skeletal metastases.
Main Methods:
- Review of preclinical models to understand tumor-bone interactions.
- Analysis of experimental and clinical studies on novel therapeutic strategies.
- Evaluation of advanced imaging techniques and serum biomarkers for diagnosis and monitoring.
Main Results:
- Preclinical research has elucidated the complex interactions between tumor cells and the bone microenvironment, identifying potential drug targets.
- Emerging therapies show promise in blocking the deleterious process of bone metastasis.
- Advanced imaging and biomarkers can improve early diagnosis and patient risk stratification.
Conclusions:
- Novel experimental and clinical approaches are crucial for addressing the unmet need in managing lung cancer bone metastases.
- A deeper understanding of tumor biology in bone and improved diagnostics are key to developing more effective treatments.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
